13 results
Oral anticoagulant dosing and bridging for VTE

- Dr. Joseph Shatzel @Clotmaster 

#VTE #DOAC #Bridging #Dosing #Oral
Oral anticoagulant ... Clotmaster #VTE #DOAC ... #Anticoagulation ... Dabigatran #Apixaban #Rivaroxaban ... #Pharmacology #Hematology
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
, edoxaban and rivaroxaban ... controlled trial ... evidence in cancer-associated ... Cancer #Algorithm #Anticoagulation ... #Management #Hematology
Heparin, Fondaparinux, and Novel Oral Anticoagulants - Pathophysiology

Anticoagulation with parenteral (intravenous or subcutaneous) and oral anticoagulants
Pathophysiology Anticoagulation ... warfarin) for chronic anticoagulation ... conformational changes in ... accelerates the bridging ... Heparins #LMWH #UFH #DOAC
Anticoagulant Bridging

 • Switching from LMWH
 • Switching from UFH
 • Switching from DOAC to Warfarin
Anticoagulant Bridging ... Switching from DOAC ... #Bridging #anticoagulation ... #pharmacology #management ... #hematology
Anticoagulant specific factor inhibition. 

#anticoagulation #clotting #INR #heparin #LMWH #NOAC #warfarin #coumadin #rivaroxaban  #Xarelto #apixaban
Anticoagulant specific ... #anticoagulation ... #clotting #INR ... warfarin #coumadin #rivaroxaban ... dabigatran #Pradaxa #management
Perioperative Management of DOACs
Problem:
 ✖ Each year approximately 250,000 patients on chronic anticoagulation in North America
Perioperative Management ... patients on chronic anticoagulation ... in North America ... to assess for anticoagulant ... Apixaban, Edoxaban, Rivaroxaban
Anticoagulation for Atrial Fibrillation - CHA2DS2-VASc

I always tell my students, one of the first thing you
for Atrial Fibrillation ... a patient with atrial ... guidelines recommend DOAC ... #CHADS2VASC #Score ... #Management
Cardiac Valve Replacement - Anticoagulation INR Targets and Antiplatelet by Valve Type

Bioprosthetic valves require at least
utilize direct oral anticoagulants ... (DOACs) for bioprosthetic ... patients with chronic atrial ... #Management #Cardiology ... #Target #DOAC #
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
DOAC, direct oral ... anticoagulant; ... #DOAC #VTE #Malignancy ... Cancer #Algorithm #Anticoagulation ... #Management #Hematology
Atrial Fibrillation (A-Fib) Summary

Symptoms:
• Palpitations, light-headedness, dizziness, dyspnea, exercise intolerance, chest pain, near-syncope, syncope.

Why?
Cardiac:
	• Valvular heart
typically needed • DOACs ... Xa inhibitors (rivaroxaban ... Warfarin: therapeutic INR ... AFib #diagnosis #management ... #cardiology